CITADEL ADVISORS LLC 13D and 13G filings for Benitec Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-02-14 6:18 pm Sale | 2023-12-31 | 13G | Benitec Biopharma Inc. BNTC | CITADEL ADVISORS LLC | 95,356 3.600% | -84,674![]() (-47.03%) | Filing |
2023-08-21 4:07 pm Purchase | 2023-08-11 | 13G | Benitec Biopharma Inc. BNTC | CITADEL ADVISORS LLC | 180,030 6.900% | 180,030![]() (New Position) | Filing |